Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Khedmati
Psy57 - A Comparison Between on Demand Usage of Rfviia vs Prophylaxis Use of Emicizumab in High Titer Inhibitory Hemophilia a Patients in Iran; A Cost Utility Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Cost-Effectiveness Analysis of Prophylaxis vs On-Demand Supply of Factor Ix in Patients Diagnosed With Moderate Hemophilia B in Colombia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Randomized Comparison of Two Prophylaxis Regimens and a Paired Comparison of On-Demand and Prophylaxis Treatments in Hemophilia a Management
Journal of Thrombosis and Haemostasis
Medicine
Hematology
Malaria Treatment vs. Malaria Prophylaxis : A Cost Comparison.
Zagazig University Medical Journal
Psy95 - Exploring the Potential Cost-Effectiveness of Emicizumab for Hemophilia a With Inhibitor in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Efficacy of Emicizumab Prophylaxis Versus Factor VIII Prophylaxis for Treatment of Hemophilia a Without Inhibitors: Network Meta-Analysis and Subgroup Analyses of the Intra-Patient Comparison of the HAVEN 3 Trial
Current Medical Research and Opinion
Medicine
Pertussis Post-Exposure Prophylaxis Among Household Contacts: A Cost-Utility Analysis
PLoS ONE
Multidisciplinary
Cost Minimization Analysis of Activated Prothrombin Complex Concentrate (Apcc) Compared to Recombinant Factor Viia (Rfviia) for Hemophilia Patients With Inhibitors
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Successful Use of Emicizumab in a Patient With Refractory Acquired Hemophilia a and Acute Coronary Syndrome Requiring Percutaneous Coronary Intervention
Research and Practice in Thrombosis and Haemostasis
Major Surgery Management in Patients With Haemophilia a and Inhibitors on Emicizumab Prophylaxis Without Global Coagulation Monitoring
British Journal of Haematology
Hematology
